Form 144 Esperion Therapeutics For: 17 June
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Esperion Therapeutics Inc (ESPR)
Track today's live Esperion (ESPR) share price, performance and key data on this page with our current NASDAQ:ESPR stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Esperion share price on the NASDAQ exchange. Use the dropdown to switch exchange for the ESPR share price, head to our technical summary section, which provides analysis on Esperion share price buy/sell indicators using real-time data (or discuss the Esperion (ESPR) stock price today with other investors in the Esperion NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:ESPR share price (ISIN: US29664W1053) to enhance your trading decisions with our free investment tools and resources.
What Is the Esperion Therapeutics Inc Share Price Today?
The Esperion share price today is 3.150.
What Is the Stock Symbol for Esperion Therapeutics Inc
The stock symbol (or 'ticker') for Esperion Therapeutics Inc is "ESPR."
What Stock Exchange Does Esperion Therapeutics Inc Trade On?
Esperion Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Esperion Therapeutics Inc a Good Stock to Buy?
Determining whether Esperion (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:ESPR share price (ISIN: US29664W1053) to enhance your trading decisions with our free investment tools and resources.
What Is the Esperion Therapeutics Inc Share Price Today?
The Esperion share price today is 3.150.
What Is the Stock Symbol for Esperion Therapeutics Inc
The stock symbol (or 'ticker') for Esperion Therapeutics Inc is "ESPR."
What Stock Exchange Does Esperion Therapeutics Inc Trade On?
Esperion Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Esperion Therapeutics Inc a Good Stock to Buy?
Determining whether Esperion (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.150
3.170
52 wk Range
0.949
4.175
ESPR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.1503.170
52 wk Range
0.9494.175
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ESPR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
3.190
Upside
+1.27%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to drop this year
- Esperion Th receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 13G Esperion Therapeutics For: 8 June
- Investing.com
- Form 144 Esperion Therapeutics For: 17 June
- Investing.com
- Form 13G Esperion Therapeutics For: 8 June
- Investing.com
- Esperion Th receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
0 Buy
6 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 3.190
(+1.27% Upside)
Esperion Therapeutics Inc Earnings Call Summary for Q4/2025
- Q4 revenue surged 144% YoY to $168.45M, driven by $124.7M collaboration revenue including Otsuka milestone payment.
- EPS of $0.22 missed forecast of $0.29 by 24%, though stock rose 7.24% in pre-market to $3.26 on revenue strength.
- US net product revenue grew 38% to $43.7M; company ended year with strong cash position and reduced debt levels.
- CEO Mayleben cited 2025 as best year on record; projects 2026 operating expenses of $225M-$255M including $15M stock compensation.
- Growth strategy focuses on new product launches and international expansion through strategic partnerships to sustain momentum.
Last Updated: 10/03/2026, 12:56
Read Full TranscriptEarnings
Latest Release
08/05/2026
EPS / Forecast
-0.10 / -0.02
Revenue / Forecast
80.1M / 95.72M
Compare ESPR to Peers and Sector
Metrics to compare | ESPR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipESPRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −109.2x | 1.6x | −0.4x | |
PEG Ratio | −1.14 | −1.43 | 0.00 | |
Price/Book | −2.6x | 1.7x | 2.6x | |
Price / LTM Sales | 1.9x | 2.0x | 3.0x | |
Upside (Analyst Target) | 0.3% | 40.6% | 58.1% | |
Fair Value Upside | Unlock | 21.0% | 8.2% | Unlock |
Esperion Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company’s marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia cardiovascular disease who require additional lowering of LDL-C. Its products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. It has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was formerly known as HDL Therapeutics, Inc. and changed its name to Esperion Therapeutics, Inc. in May 2008. The company was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Esperion (NASDAQ: ESPR) Share Price Today?
The Esperion stock price today is 3.150 USD.
What Stock Exchange Does Esperion (ESPR) Trade On?
Esperion is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Esperion?
The stock symbol (also called a 'ticker') for Esperion is "ESPR."
What Is the Current Esperion Market Capitalisation?
As of today, Esperion (NASDAQ: ESPR) market cap is 810.910M USD.
What Is Esperion's (ESPR) Earnings Per Share (TTM)?
The Esperion EPS is currently -0.034 (Trailing Twelve Months).
When Is the Next Esperion Earnings Date?
Esperion's next earnings report will be released on 04/08/2026.
Is ESPR a Buy or Sell From a Technical Analyst Perspective?
Based on today's Esperion moving averages and other technical indicators, the daily buy/sell signal for ESPR stock is Strong Buy.
How Many Times Has Esperion Stock Split?
Esperion has split 0 times. (See the ESPR stock split history page for full effective split date and price information.)
How Many Employees Does Esperion Have?
Esperion has 294 employees, based on their latest Companies House report.
What is the current trading status of Esperion (NASDAQ: ESPR)?
As of 22/06/2026, Esperion (ESPR) is trading at a share price of 3.150 USD, with a previous close of 3.150 USD. The stock has fluctuated within a day range of 3.150 USD to 3.170 USD, while its 52-week range spans from 0.949 USD to 4.175 USD.
What Is Esperion (ESPR) Price Target According to Analysts?
The average 12-month price target for Esperion is 3.190 USD, with a high estimate of 3.28 USD and a low estimate of 3.16 USD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +1.27% Upside potential.
What Is the ESPR Premarket Price?
ESPR's last pre-market stock price is 3.160 USD. The pre-market share volume is 22,700.000, and the stock has decreased by 0.010, or 0.320%.
What Is the ESPR After Hours Price?
ESPR's last after hours stock price is 3.120 USD, the stock has decreased by -0.030, or -0.950%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.